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2Abstract22
Various pharmaceutical drugs are being detected in different environmental compartments23
such as surface waters, groundwater, and sediment; a major concern since they are24
biologically active substances which can interfere with biological systems affecting the native25
biota. Among these drugs, antimicrobials are especially worrisome mainly due to the26
development of bacterial resistance. The aims of the present study were to investigate if27
enrofloxacin, an emergent antibiotic pollutant, could be biodegraded in lake sediment,28
identify its break down products and to determine if these products have antimicrobial29
properties or are toxic. Three biodegradation products were identified and the antibiotic30
susceptibility assay proved that the products formed did not display antibiotic effects.31
Ecotoxicity testing with green algae suggested that the degradation products do not cause32
adverse effects statistically. However, it is suggested that further investigations are needed to33
identify the mechanism of degradation and the microbes involved.34
35
Keywords: Enrofloxacin, biodegradation, lake sediment, antibiotic susceptibility,36
ecotoxicology37
31. Introduction38
The presence and persistence of pharmaceuticals in the environment and their fate are39
increasingly pertinent issues (Álvarez-Ruiz et al., 2015; Ngumba et al., 2016). Parallel to this,40
there are concerns regarding the preservation of aquatic ecosystems and the potential41
contamination risk of public water supplies. This has encouraged studies aimed at identifying42
and quantifying pharmaceutical waste in the environment so that the risk posed can be43
evaluated, and subsequently, the disposal thereof can be minimized and efficient processes to44
remove these drugs can be developed (Maranho et al., 2014; Mwanamoki et al., 2014;45
Álvarez-Ruiz et al., 2015).46
Considering the significant threat to humans, animals, and agriculture, antibiotics are one of47
the most relevant emerging pollutants in the environment. Their continuous interactions with48
and inhibitory effects on microorganisms may cause damage, including antibiotic resistance49
induction (Adachi et al., 2013). Fluoroquinolones, such as enrofloxacin, are broad-spectrum50
synthetic antibiotics commonly used in human and veterinary medicine (Trouchon and51
Lefebvre, 2016) as well as in agriculture and aquaculture (Migliore et al., 1996).52
Fluoroquinolone antibiotics typically have a fluoro group attached to the central ring structure53
at position 6. Enrofloxacin is distinguished by three ionisable functional groups, namely a54
piperazine substituent at N-4, a dihydroquinoline ring at N-1, and the 3-carbonyl group (Fig55
1). These antibiotics show strong antibacterial activity and are somewhat resistant to abiotic56
and biotic degradation (Migliore et al., 1996). Orally administered as medicines, only a small57
percentage of fluoroquinolones are adsorbed and metabolized, the rest is excreted. For most58
fluoroquinolones, the elimination half-life has been reported to be 16 h and it is therefore59
likely that they will be excreted largely unchanged with less than 25% metabolization. Within60
this context, fluoroquinolones are acknowledged pollutants that have already been detected in61
different environmental compartments, such as up to 248 ng l-1 in surface waters (Wagil et al.,62
42014), up to 49 ng l-1in groundwater (Ma et al., 2015), and up to 7.7 mg kg-1 in sediment (Hu63
et al., 2012) have been reported.64
Figure 1 here.65
Another important factor to consider regarding pharmaceutical pollution is that during66
wastewater treatment or even in the environment, the pollutants may be only partially67
degraded and thus numerous transformation products (TPs) are generated which may be more68
toxic than the precursor molecules (Escher and Fenner, 2011). Generally, drugs and their TPs69
are found in sub-µg l-1 concentrations in unknown complex matrices making it necessary to70
use analytical methods of high sensitivity and selectivity to detect and identify them.71
Moreover, the lack of analytical standards for TPs complicates the analysis thereof.72
Identifying unknown compounds where standards are not available is challenging. The first73
step is assessing whether prediction of TPs using computational (in-silico) prediction tools is74
possible. Furthermore, a proper prediction of their formation may be done considering the75
organism or the system where the TPs are formed (Bletsou et al., 2015). In a second step,76
when it is possible to draw up a list of potential TPs assembled from the literature or from77
prediction models, a suspect screening can be done in samples for those candidates. However,78
whenever predictions are unavailable, non-target screening analyses are performed to identify79
novel TPs with sophisticated post-acquisition data tools, like MZmine80
(http://mzmine.sourceforge.net/), and supplementary analytical techniques (Bletsou et al.,81
2015).82
The abiotic and biotic degradation of several pharmaceuticals in sediments and the water83
column are well understood (Löffler et al., 2005; Jiang et al., 2010), however, little data on84
the fate of enrofloxacin are available and if its TPs are equally, or potentially even more85
harmful than the parent compound. Due to the inability of wastewater treatment processes to86
5fully eliminate pharmaceuticals, together with various contamination input sources,87
antibiotics such as fluoroquinolones, especially enrofloxacin, are bound to end up in the88
environment as already evident from monitoring studies (reviewed by Homem and Santos,89
2011). It is therefore important to understand the environmental fate of these compounds and90
the ecological threat their natural breakdown products may pose to the environmental91
compartments they accumulate in.92
The aims of the present study were, therefore, to identify the TPs of enrofloxacin in lake93
sediments and to test the formed TPs for antimicrobial properties and their ecotoxicological94
effects using a modified antimicrobial susceptibility test and a green algae growth test,95
respectively, to understand the fate and effects of enrofloxacin pollution on the environment,96
specifically freshwater lakes..97
62. Materials and methods98
2.1 Biodegradation with lake sediments99
Sediment samples were collected from Müggelsee, a lake in the eastern suburbs of Berlin, the100
capital city of Germany, approximately 200 m from the shoreline by removing the first 15 cm101
of sediment using a bottom sampler. After drying the sediment at 30°C, a dry weight of 1 g102
per sediment sample was used per replicate for both the treatment and the controls. Three103
controls were prepared, i.e. 1) 10 mg l-1 enrofloxacin in 10 ml water to test its natural104
degradation, 2) 10 ml water lacking enrofloxacin in the natural sediment from Müggelsee to105
investigate if the sediment was previously contaminated with enrofloxacin, and 3) 10 mg l-1106
enrofloxacin (10 ml) in sterilized sediment to eliminate the influence of the native microflora.107
The sediment samples were sterilized by autoclaving at 121°C for 35 min (16 psi). For the108
treatment samples, 10 ml of 10 mg enrofloxacin l-1 was added to the natural sediments109
samples from Müggelsee. The samples were incubated at 20°C, shaking at 145 rpm, in the110
absence of light. Thereafter, batch experiments were performed in duplicate for different111
periods of time exposures (5, 24, 48, and 72 h). After centrifugal separating at 1700 × g, 1 ml112
of supernatant was collected for direct analysis, after filtration. To concentrate the remaining113
supernatant volume, the samples were lyophilized and reconstituted with 1 ml of a 5%114
acetonitrile solution in ultrapure water. The sediments from the treatment samples were115
extracted with sequential acetonitrile and methanol solvents steps. The extracts were116
lyophilized and reconstituted in 1 ml of a 5% acetonitrile solution in ultrapure water and117
analysed. The recovery of enrofloxacin after concentration was test in methanol, acetonitrile,118
and water (n=3) by spiking with 1 mg l-1 enrofloxacin before freeze drying at −50.3 °C and a119
pressure of 6.1 mbar in a Lio 5P lyophilisator (Kambič Laboratorijska oprema). The method120
recovery percentage ranged from 76 to 103% for the three solvents.121
7The exposure concentration of 10 mg l-1 enrofloxacin (soluble up to 146 mg l-1 in water) was122
selected in order for all breakdown products produced to be identified, i.e. that the123
concentration of a specific TP did not fall below the limit of detection (10 pg on column) and124
quantification (50 pg on column). Also, the concentration selected also serves as a worst case125
scenario to assess the effect of breakdown products of enrofloxacin in the environment.126
127
2.2 Product identification using qualitative analysis128
The prepared samples were analysed using Liquid Chromatography Electrospray Ionization129
Quadrupole Ion-Mobility Time-of-Flight Mass Spectrometry (LC-ESI-IMS-TOF) (Waters130
Co.), subjected to high-resolution mass spectrometry. Chromatographic separation was131
achieved on a Kinetex C18 column (100 mm x 2.1 mm; 2.6 μm; Phenomenex) eluted with132
mixtures of 0.1% formic acid in ultrapure water (solvent A) and 0.1% formic acid in133
acetonitrile (solvent B) starting with 5% B for 3 min. Over the next 9 min, mobile phase B134
was increased from 5 to 60% and further to 95% over the next 2 min. From the 14th to the 20th135
min mobile phase B was kept constant at 95% B. Over the next 2 min phase B was reduced to136
5% and the column was allowed to re-equilibrate for 4 min before the next injection. The137
oven temperature was set at 40°C, the flow rate was 0.25 ml min-1 and the injection volume138
was 5 µl. The mass spectrometric analyses were performed in the positive ionization mode139
(electrospray), and the operating conditions were as follows: drying gas flow: 8 l min-1;140
desolvation temperature: 200°C; capillary voltage: 4.5 kV; nebulizer pressure: 4 bar; spectra141
acquisition rate: 2 Hz at full MS mode, operating with a scan range from m/z 50 to m/z 1000.142
Using the described analytical settings, enrofloxacin had a retention time of 6.51 min and m/z143
of 360.1. MZmine 2 (Version 2.21) which is a modular framework for processing, visualizing,144
8and analysing mass spectrometry-based molecular profile data, was used for data extraction,145
deconvolution, and alignment (Bletsou et al., 2015).146
2.3 Ecotoxicological tests147
The freshwater algae growth rate inhibition test with the single-celled green algae148
Desmodesmus subspicatus was performed according to the DIN EN ISO 8692:2012-06.149
For the antibiotic susceptibility assay, three controls at the inception of the experiment were150
prepared, i.e. Provisoli medium (Pflugmacher et al., 2006) as negative control for media151
samples, enrofloxacin at a concentration of 10 mg l-1 in media as a positive control, and152
unexposed sediment as a negative sediment control. The effect of the sediment microbe153
population on the antibiotic nature of enrofloxacin was evaluated by preparing a negative154
control of media and sediment, 10 mg l-1 enrofloxacin in media together with the sediment,155
and 10 mg l-1 enrofloxacin in media with autoclaved sediment. All exposure sets were156
conducted in quadruplicate.157
A modified version of the Kirby Bauer disk diffusion assay (Bauer et al. 1996), was used to158
evaluate the bactericidal effect of enrofloxacin after treatment with the sediments microbes. In159
short, single colonies of Escherichia coli Top 10 (ThermoFisher Scientific) were aseptically160
transferred to nutrient broth and cultivated overnight at 37°C. Thereafter, spread plates of the161
culture were prepared on nutrient agar (prepared according to supplier specifications) and162
allowed to dry for 5 minutes. Sterile diffusion disks were dipped in each of the samples and163
placed on the prepared plates (one disk per replicate per plate). The plates were incubated164
overnight at 37°C. The inhibition zone radius per replicate was determined in millimetre.165
2.4 Statistical analysis166
9Statistical analysis was performed using Statistical Package for Social Sciences (SPSS)167
software (version 21, SPSS, Inc., Chicago, IL, USA; α= 0.05, 95 % CI). Data were tested for168
normality and homogeneity of variance using Shapiro-Wilk test and Levene’s test,169
respectively. A one-way analysis of variance test was performed followed by a Turkey´s post-170
hoc-test to identify significant differences between the treatments and controls (α= 0.05).171
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3. Results and discussion172
3.1 Degradation products identification173
For the first three sampling points, i.e. 5, 24, and 48 h, the concentration of enrofloxacin174
remained statistically constant in the controls and treatments (p > 0.05) and no TP products175
could be identified, probably as the concentration of the TPs were below the limit of176
detection. The results obtained in the control experiments are presented in Fig 2. Comparing177
Fig 2A versus 2B it is evident that during the three days of exposure, the enrofloxacin178
concentration of 10 mg l-1 in media remained unchanged (p > 0.05), demonstrating its stability179
under the experimental conditions. Fig 2C showed that no free enrofloxacin could be detected180
in the untreated sediment..181
Figure 2 here.182
In the control experiment, which consisted of enrofloxacin in the sterile sediment, neither183
enrofloxacin nor TPs could, however, not be detected after 72 h of incubation (Fig 2D)184
suggesting that it could have adsorbed to the sediment. Fluoroquinolones have previously185
been reported to form strong bonds with ions such Ca2+, Mg2+, Fe3+ or Al3+ causing them to186
adsorb onto sewage, sludge, soil, and sediment, which is said to cause their environmental187
resilience and resistance to microbial degradation (Al-Ahmad et al., 1999; Ingerslev and188
Halling-Sørensen, 2000; Kümmerer et al., 2000). Enrofloxacin is said to have a very high189
affinity for sludge, soils, and sediments (Van Doorslaer et al., 2014). Compared to other190
antibiotics, fluoroquinolones have a very high sorbent coefficient of 260 to 5610 l kg-1191
(Nowara et al., 1997). It was previously shown that the adsorption of fluoroquinolones onto192
clay surfaces is attributed to the carboxylic acid moiety binding the positively charged clay193
surface (Stern layer), which coincidentally is also the functional moiety responsible for gyrase194
binding together with the ketone of C4 (Nowara et al., 1997; Marengo et al., 1997).195
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After 72 h, no enrofloxacin could be detected in the treated samples. Using the software196
MZmine, after peak deconvolution and alignment of the chromatograms obtained from the197
treatment and control samples, three compounds were identified in the enrofloxacin treated198
natural sediment samples, i.e. two degradation products were found in the concentrated media199
samples (m/z 308 and m/z 332) and another in the sediment extracts (m/z 318).200
Figure 3 here.201
Fig 3 (A to C) presents the high-resolution MS/MS spectrums obtained to confirm the202
proposed structures. All degradation products identified were formed through modifications203
occurring in the essential structure of the quinolones. For all three TPs, the piperazine ring204
remained unchanged (Fig 4). The two TPs in the concentrated media samples were identified205
as 2-Cyclopropylamino-4-(4-ethyl-1-piperazinyl)-5-fluorobenzoic acid (m/z 308) and 1-206
Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-3-hydroxy-4-1H-quinolinone (m/z 332), and207
the TP in the sediment extract was identified as 1-Cyclopropyl-6-(4-ethyl-1-piperazinyl)-5-208
fluoro-1H-indole-2,3-dione (m/z 318). The degradation of enrofloxacin by the brown rot209
fungus Gloeophyllum striatum and the metabolites formed were previously investigated210
(Wetzstein et al., 1997). All three the degradation products identified in the present study211
were also described by Wetzstein et al. (1997), suggesting that the degradation could be212
attributed to microbial degradation. As no degradation products were detected in the control,213
where enrofloxacin was incubated with sterile sediment, this hypothesis is further supported,214
however, this should be further investigated in future to investigate if microbes were involved215
and if so, which microbes were responsible for the TPs identified.216
Figure 4 here.217
Decarboxylation occurred in the essential structure of the enrofloxacin (Fig 4), which218
irreversibly inactivates the drug because the carboxyl group is essential for the antibacterial219
12
activity of fluoroquinolones (Domagala, 1994). The cleavage of the heterocyclic core of220
enrofloxacin was observed in the intermediate A and B (Fig 4).221
3.2 Ecotoxicological tests222
The algae growth rate inhibition test (Fig 5) showed that the TPs formed had no significant223
effect on the specific growth rate of D. subspicatus compared to when cultivated in growth224
media only (negative control) (p = 0.087). Interestingly, enrofloxacin was previously reported225
to be toxic to green algae with an EC50 of 5,568 µg l-1 (Ebert et al., 2011). Yet, in the present226
study, a concentration of 10 mg l-1 enrofloxacin had no statistical effect on the specific growth227
rate compared to that of the control (p = 0.426).228
The microalgae displayed the best specific growth rate in the samples from which229
enrofloxacin was incubated in sterile sediment for three days. It is plausible that the230
enrofloxacin was bound to the sediment, therefore unable to adversely affect the algae. The231
algae also could have benefitted from the addition of minerals and micronutrients supplied232
form samples in contact with the sediment.233
Figure 5 here.234
The antibiotic susceptibility assay (Fig 6) showed that after the 72 h biodegradation period of235
enrofloxacin (Treatment (sediment) and (liquid)), the products formed in the solution as well236
as those bound to the sediment, lost their antibiotic effects compared to the 10 mg l-1237
enrofloxacin solution (Enro initial) (p < 0.05). This was expected as it was shown for the TP238
identification that enrofloxacin was decarboxylated. Interestingly, incubation of enrofloxacin239
with the sterilized sediment reduced the antibacterial properties of the enrofloxacin by 1.8-240
fold in the sediment (Positive control (sediment)) and 3.2-fold in the media (Positive control241
(media)) (p < 0.05). As sediment binding was previously proposed to occur via the carboxyl242
13
group (Marengo et al., 1997), which is essential for its antibacterial activity (Wetzstein,243
2001), complete loss of the property was expected.244
Figure 6 here.245
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4. Conclusions246
The applied strategy for the analysis of the biodegradation of enrofloxacin in lake sediment247
allowed the detection and the identification of three TPs. All TPs identified were formed248
through modifications occurring in the essential structure of the quinolones, however, the249
piperazine ring remained unchanged. The antibiotic susceptibility assay showed that, after250
biodegradation, the products formed in the solution lost the antibiotic effects. In support, the251
algal growth inhibition assay suggests that the degradations products formed did not affect the252
growth rate of algae. It is also suggested that further investigations are needed to obtain an in-253
depth understanding of the effects of enrofloxacin degradation products on organisms existing254
in aquatic environments.255
256
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Figure captions:341
342
Figure 1: Chemical structure of enrofloxacin; 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-343
fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid344
345
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346
Figure 2: Total ion chromatograms of enrofloxacin (RT 6.5 min; 360 m/z) in the control347
experiments via LC-ToF (ESI (+) MS- full scan mode) analyses; A) the enrofloxacin solution348
(10 mg l-1) at the start of the experiment, B) the enrofloxacin concentration after 72 h of349
incubation in the absence of sediment, C) 10 ml water lacking enrofloxacin in sediment after350
72 h, D) autoclaved sediments exposed to 10 mg l-1 enrofloxacin for 72 h351
21
352
Figure 3: Mass spectrum obtained from analyzes by LC-ToF (ESI (+) MS / MS) after 72 h of353
exposure with lake sediment for the intermediate structure identification of A) m/z 308, B)354
m/z 318, and C) m/z 332355
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356
Figure 4: The three TPs of enrofloxacin identified in sediment from Müggelsee after 72 h;357
namely 2-Cyclopropylamino-4-(4-ethyl-1-piperazinyl)-5-fluorobenzoic acid (m/z 308), 1-358
Cyclopropyl-6-(4-ethyl-1-piperazinyl)-5-fluoro-1H-indole-2,3-dione (m/z 318), and 1-359
Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-3-hydroxy-4-1H-quinolinone (m/z 332)360
361
Figure 5: Specific growth rate of Desmodesmus subspicatus after 72 h of exposure to362
enrofloxacin at a concentration of 10 mg l-1 (positive control), media devoid of enrofloxacin363
23
(negative control), the TPs of enrofloxacin after biodegradation in Müggelsee sediment after364
72 h, and the products of enrofloxacin in sterilized sediment after 72 h. Data represent average365
µ ± standard deviation (n = 4).366
367
Figure 6: Antibiotic susceptibility test for enrofloxacin biodegradation in sediment from368
Müggelsee. Enro initial represents an enrofloxacin solution of 10 mg l-1, media was devoid of369
enrofloxacin (control), the negative control represented media devoid of enrofloxacin370
incubated in the natural sediment for 72 h, treatment represented media containing 10 mg l-1371
enrofloxacin incubated with the natural sediment for 72 h, and the positive control represented372
media containing 10 mg l-1 enrofloxacin incubated with the sterilized sediment for 72 h. Data373
represents the average inhibition zone (mm) ± standard deviation (n = 4)374
